198 related articles for article (PubMed ID: 36757008)
1. Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease.
Leta V; Klingelhoefer L; Longardner K; Campagnolo M; Levent HÇ; Aureli F; Metta V; Bhidayasiri R; Chung-Faye G; Falup-Pecurariu C; Stocchi F; Jenner P; Warnecke T; Ray Chaudhuri K;
Eur J Neurol; 2023 May; 30(5):1465-1480. PubMed ID: 36757008
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease.
Pfeiffer RF; Isaacson SH; Pahwa R
Parkinsonism Relat Disord; 2020 Jul; 76():63-71. PubMed ID: 32461054
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
Lolekha P; Sriphanom T; Vilaichone RK
PLoS One; 2021; 16(5):e0251042. PubMed ID: 33945559
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication for Parkinson's disease.
Rees K; Stowe R; Patel S; Ives N; Breen K; Clarke CE; Ben-Shlomo Y
Cochrane Database Syst Rev; 2011 Nov; (11):CD008453. PubMed ID: 22071847
[TBL] [Abstract][Full Text] [Related]
5. Effects of Helicobacter pylori on Levodopa Pharmacokinetics.
Nyholm D; Hellström PM
J Parkinsons Dis; 2021; 11(1):61-69. PubMed ID: 33164946
[TBL] [Abstract][Full Text] [Related]
6. The role of small intestinal bacterial overgrowth in Parkinson's disease.
Fasano A; Bove F; Gabrielli M; Petracca M; Zocco MA; Ragazzoni E; Barbaro F; Piano C; Fortuna S; Tortora A; Di Giacopo R; Campanale M; Gigante G; Lauritano EC; Navarra P; Marconi S; Gasbarrini A; Bentivoglio AR
Mov Disord; 2013 Aug; 28(9):1241-9. PubMed ID: 23712625
[TBL] [Abstract][Full Text] [Related]
7. Motor fluctuations and Helicobacter pylori in Parkinson's disease.
Rahne KE; Tagesson C; Nyholm D
J Neurol; 2013 Dec; 260(12):2974-80. PubMed ID: 24002418
[TBL] [Abstract][Full Text] [Related]
8. Gut dysfunction in Parkinson's disease.
Mukherjee A; Biswas A; Das SK
World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
[TBL] [Abstract][Full Text] [Related]
9. Irregular gastrointestinal drug absorption in Parkinson's disease.
Nyholm D; Lennernäs H
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection.
Narożańska E; Białecka M; Adamiak-Giera U; Gawrońska-Szklarz B; Sołtan W; Schinwelski M; Robowski P; Madaliński MH; Sławek J
Clin Neuropharmacol; 2014; 37(4):96-9. PubMed ID: 24992088
[TBL] [Abstract][Full Text] [Related]
11. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
Melamed E; Zoldan J; Galili-Mosberg R; Ziv I; Djaldetti R
J Neural Transm Suppl; 1999; 56():173-83. PubMed ID: 10370911
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis.
Zhong R; Chen Q; Zhang X; Li M; Lin W
J Neurol; 2022 Feb; 269(2):703-711. PubMed ID: 33616741
[TBL] [Abstract][Full Text] [Related]
13. Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease.
Kianirad Y; Simuni T
Curr Neurol Neurosci Rep; 2016 Apr; 16(4):34. PubMed ID: 26898686
[TBL] [Abstract][Full Text] [Related]
14. Gastric emptying time and gastric motility in patients with Parkinson's disease.
Hardoff R; Sula M; Tamir A; Soil A; Front A; Badarna S; Honigman S; Giladi N
Mov Disord; 2001 Nov; 16(6):1041-7. PubMed ID: 11748735
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.
van Kessel SP; Bullock A; van Dijk G; El Aidy S
mSystems; 2022 Feb; 7(1):e0119121. PubMed ID: 35076270
[TBL] [Abstract][Full Text] [Related]
16. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
17. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.
Djaldetti R; Ziv I; Melamed E
Isr J Med Sci; 1996 Dec; 32(12):1224-7. PubMed ID: 9007159
[TBL] [Abstract][Full Text] [Related]
18. Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.
Barichella M; Cereda E; Cassani E; Pinelli G; Iorio L; Ferri V; Privitera G; Pasqua M; Valentino A; Monajemi F; Caronni S; Lignola C; Pusani C; Bolliri C; Faierman SA; Lubisco A; Frazzitta G; Petroni ML; Pezzoli G
Clin Nutr; 2017 Aug; 36(4):1054-1061. PubMed ID: 27406858
[TBL] [Abstract][Full Text] [Related]
19. Gastro-intestinal dysfunctions in Parkinson's disease (Review).
Ivan IF; Irincu VL; Diaconu Ș; Falup-Pecurariu O; Ciopleiaș B; Falup-Pecurariu C
Exp Ther Med; 2021 Oct; 22(4):1083. PubMed ID: 34447476
[TBL] [Abstract][Full Text] [Related]
20. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
